| 摘要 |
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: there are offered compounds for injections in local lipopexia regions, containing a prolonged selective beta-2-adrenergic receptor agonist selected from salmeterol, formoterol, their salts and their solvates; a compound for decreasing fatty tissue desensitisation to the beta-adrenergic receptor agonist (or a compound for decreasing target tissue desensitisation to the beta-adrenergic receptor agonist - a version); and a liquid carrier, a related method of local treatment of lipopexia regions (versions), a method of decreasing fatty tissue. It is shown that combined use of the ingredients surpasses an effect (e.g., waist size) as compared with intake of only one of them. ^ EFFECT: development of the method of decreasing fatty tissue. ^ 30 cl, 1 dwg |
